WO2008145854A8 - Pharmaceutical and/or cosmetic composition containing peptides - Google Patents

Pharmaceutical and/or cosmetic composition containing peptides Download PDF

Info

Publication number
WO2008145854A8
WO2008145854A8 PCT/FR2008/000577 FR2008000577W WO2008145854A8 WO 2008145854 A8 WO2008145854 A8 WO 2008145854A8 FR 2008000577 W FR2008000577 W FR 2008000577W WO 2008145854 A8 WO2008145854 A8 WO 2008145854A8
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical
active agent
cosmetic composition
relates
composition containing
Prior art date
Application number
PCT/FR2008/000577
Other languages
French (fr)
Other versions
WO2008145854A1 (en
Inventor
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Original Assignee
Soc Extraction Principes Actif
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Extraction Principes Actif, Farra Claude Dal, Nouha Domloge, Jean-Marie Botto filed Critical Soc Extraction Principes Actif
Publication of WO2008145854A1 publication Critical patent/WO2008145854A1/en
Publication of WO2008145854A8 publication Critical patent/WO2008145854A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/415—Cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/80—Cytochromes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a cosmetic or pharmaceutical, and in particular dermatological, composition comprising, in a physiologically suitable medium, cytochrome c-derived peptides, as active agent, alone or in combination with at least one other active agent. The invention also relates to the use of cytochrome c-derived peptides, as active agent, in a cosmetic composition for stimulating the defences and protection of the skin, in particular against oxidative damage. The invention also relates to a cosmetic treatment process for protecting the skin and the appendages against external attacks and for combating skin ageing.
PCT/FR2008/000577 2007-04-27 2008-04-23 Pharmaceutical and/or cosmetic composition containing peptides WO2008145854A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0703058 2007-04-27
FR0703058A FR2915394B1 (en) 2007-04-27 2007-04-27 PHARMACEUTICAL AND / OR COSMETIC COMPOSITION CONTAINING PEPTIDES

Publications (2)

Publication Number Publication Date
WO2008145854A1 WO2008145854A1 (en) 2008-12-04
WO2008145854A8 true WO2008145854A8 (en) 2009-07-16

Family

ID=38736018

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000577 WO2008145854A1 (en) 2007-04-27 2008-04-23 Pharmaceutical and/or cosmetic composition containing peptides

Country Status (2)

Country Link
FR (1) FR2915394B1 (en)
WO (1) WO2008145854A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948876B1 (en) * 2009-08-07 2011-11-04 Oreal ASSOCIATION OF LUMINOUS RADIATION AND A PEPTIDE AGENT INCREASING THE EXPRESSION OF A CYTOCHROME C OXIDASE SUBSTRATE TO IMPROVE THE APPEARANCE OF THE SKIN AND / OR THE HAIR
CN113307851B (en) * 2021-06-11 2022-04-29 珠海医美企业管理有限公司 Application of active peptide and mesenchymal stem cell exosome for improving skin physiological characteristics in medicines or cosmetics

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2365949A1 (en) * 1999-04-16 2000-10-26 Children's Medical Center Corporation Adhesion modulatory peptides and methods for use
EP1301786B1 (en) * 2000-07-21 2005-11-30 Evotec AG Method for the detection of apoptosis by determining cytochrome c as apoptosis-specific marker released into an extracellular medium through cellular release mechanisms
AU2001294880A1 (en) * 2000-09-27 2002-04-08 The Uab Research Foundation Non-replicative particulate vaccine delivery system and methods of making and using same
EP1356048A2 (en) * 2000-12-04 2003-10-29 Argonex Pharmaceuticals Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
AU2003292326A1 (en) * 2002-11-08 2004-06-03 Societe D'extraction Des Principes Actifs (Vincience) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
ES2540459T3 (en) * 2004-03-12 2015-07-09 Ashland Specialties France Use of peptides as an antioxidant agent for the preparation of a cosmetic and / or pharmaceutical composition
WO2007058625A1 (en) * 2005-11-15 2007-05-24 Nanyang Polytechnic Toxin-antitoxin system and applications thereof
EP1864996A1 (en) * 2006-06-06 2007-12-12 Helmholtz-Zentrum für Infektionsforschung GmbH Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker.

Also Published As

Publication number Publication date
FR2915394A1 (en) 2008-10-31
WO2008145854A1 (en) 2008-12-04
FR2915394B1 (en) 2012-12-14

Similar Documents

Publication Publication Date Title
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
WO2010109400A3 (en) Sunscreen composition comprising hydroxyapatite as physical solar filter
WO2007129270A8 (en) Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
WO2010082175A3 (en) Kxk-peptide compositions for cosmetic and dermo-pharmaceutic uses
WO2009034559A3 (en) Cosmetic process for aesthetic and/or repairing treatment of the skin
EP2144608A4 (en) Sunscreen compositions and methods
WO2013178965A3 (en) Active ingredients activating mitophagy in skin cells and use of same for improving skin condition
WO2010020424A3 (en) Use of glucosylglycerol
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
EP3330252A3 (en) Isoprenyl compounds and methods thereof
WO2010056675A3 (en) Antioxidant compositions for the cleansing and conditioning of skin
WO2007130725A3 (en) Use of hmgb1 for protection against ischemia reperfusion injury
WO2012022478A3 (en) Filler composition comprising beta-glucans
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2008139123A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2008145849A3 (en) Pharmaceutical and/or cosmetic composition containing aconitase-activating active ingredients
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
EP2241573A3 (en) Peptide derivatives and cosmetic composition comprising the same
WO2012001246A3 (en) Use of a peptidic pea extract as an active antioxidant in a cosmetic composition
WO2008114376A1 (en) Melanogenesis inhibitory composition
WO2008145854A8 (en) Pharmaceutical and/or cosmetic composition containing peptides
WO2018094023A3 (en) Cyclic dipeptides and wound healing
WO2010112712A3 (en) Novel proteasome-activating anti-aging peptides and compositions containing same
WO2008145855A8 (en) Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08805496

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08805496

Country of ref document: EP

Kind code of ref document: A1